Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04655612
What this trial is testing

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

Who this might be right for
COVID-19SARS-CoV InfectionRheumatoid Arthritis+3 more
University Hospital, Montpellier 5,000
Not applicableStudy completedNCT05083130
What this trial is testing

Awake Prone Positioning in Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV2 InfectionCOVID-19 Acute Respiratory Distress Syndrome+2 more
Oxford University Clinical Research Unit, Vietnam 93
Early research (Phase 1)Study completedNCT04661839
What this trial is testing

A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults

Who this might be right for
COVID-19
Emergent BioSolutions 28
Large-scale testing (Phase 3)Study completedNCT05780281
What this trial is testing

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 367
Large-scale testing (Phase 3)Study completedNCT04600895
What this trial is testing

The Prevent Severe COVID-19 (PRESECO) Study

Who this might be right for
Covid19
Appili Therapeutics Inc. 1,187
Early research (Phase 1)Study completedNCT04532294
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Who this might be right for
Covid19
BeiGene 18
Not applicableUnknownNCT04490473
What this trial is testing

Turkish of the SARS-CoV-2 Anxiety Scale

Who this might be right for
AnxietySARS-CoV Infection
DILEK SAYIK 300
Not applicableStudy completedNCT04609774
What this trial is testing

Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019

Who this might be right for
Coronavirus Disease (COVID-19)
Hospital Italiano de Buenos Aires 8
Not applicableActive Not RecruitingNCT06082518
What this trial is testing

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

Who this might be right for
Post COVID-19 ConditionPost-COVID-19 SyndromePost-COVID Syndrome+3 more
Sunnybrook Health Sciences Centre 40
Not applicableStudy completedNCT04859023
What this trial is testing

Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).

Who this might be right for
SARS-CoV Infection
Centre Hospitalier Universitaire de Saint Etienne 10,000
Not applicableStudy completedNCT05074017
What this trial is testing

COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests

Who this might be right for
COVID-19SARS-CoV2 InfectionSARS (Disease)
Synlab Holding Deutschland GmbH 2,222
Not applicableWithdrawnNCT04359459
What this trial is testing

Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study

Who this might be right for
COVID-19
University Medical Center Groningen
Post-approval studies (Phase 4)UnknownNCT04359615
What this trial is testing

Favipiravir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Not applicableStudy completedNCT05894590
What this trial is testing

Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,680
Testing effectiveness (Phase 2)Study completedNCT05142514
What this trial is testing

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 629
Testing effectiveness (Phase 2)UnknownNCT04355247
What this trial is testing

Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm

Who this might be right for
Covid-19
Auxilio Mutuo Cancer Center 20
Not applicableWithdrawnNCT04739449
What this trial is testing

'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission

Who this might be right for
SARS-CoV InfectionCovid19
University of Michigan
Not applicableStudy completedNCT04324489
What this trial is testing

DAS181 for Severe COVID-19: Compassionate Use

Who this might be right for
COVID-19
Renmin Hospital of Wuhan University 4
Large-scale testing (Phase 3)UnknownNCT04683328
What this trial is testing

The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care

Who this might be right for
Covid19
Sinocelltech Ltd. 560
Not applicableUnknownNCT06047067
What this trial is testing

Bioaerosol Sampling Device (BSD) Clinical Study

Who this might be right for
COVID-19
Cantor BioConnect, Inc. 330
Next Page